Dr. Kröger is a research scientist at the Centre d’excellence sur le vieillissement de Québec (CEVQ) du CIUSSSCN and an adjunct professor at the Faculté de pharmacie de l’Université Laval and at the Department of Family Medicine of McGill University. A pharmacist and (pharmaco-) epidemiologist by training, Dr Kröger uses data from epidemiological cohort studies or from administrative data banks for her research. She also performs systematic, scoping or mixed methods knowledge syntheses. For over 10 years, she has been studying risk factors for dementia (Interview with the Australian Broadcasting Corporation, Seafood: mercury and dementia, http://www.abc.net.au/radionational/programs/(healthreport/seafood,-mercury,-and-dementia./7149328, ABC).
Dr. Kröger’s current research program focuses on the medication treatment of seniors affected by dementia. It aims at improving medication use and, more specifically, deprescribing medications of questionable benefit (http://pourvivreensante.com/est-ce-que-je-prends-trop-de-medicaments/). Since 2013, she has been leading intervention and evaluation studies in long-term care facilities to assess whether interdisciplinary knowledge exchange interventions, together with critical medication reviews based on validated criteria, are successful in deprescribing medications of questionable benefit and to decrease residents’ medication load.(« OptimaMed » and « PEPS » studies http://www.ciusss-capitalenationale.gouv.qc.ca/sites/default/files/medication_demence_severe_oct2015.pdf).
Furthermore, Dr. Kröger is an affiliated researcher at the Institut national de santé publique du Québec (INSPQ) where she collaborates in the surveillance of dementia and related diseases in the Quebec population (https://www.inspq.qc.ca/es/node/4223).She is also a member of the Scientific Council of the Institut national d’excellence en santé et en services sociaux (INESSS) and a scientist member of the Ethics Research Board of the CIUSSSCN.
HSS
1050, chemin Sainte-Foy
L2-30
Québec, Québec
Canada G1S 4L8
Latest news
Data not available
New opioid prescription claims and their clinical indications: results from health administrative data in Quebec, Canada, over 14 years
Journal ArticleBMJ Open, 14 (4), 2024.
Surveillance des troubles neurocognitifs majeurs: prévalence, incidence, utilisation des services hospitaliers et des médicaments de 2000 à 2019
BookInstitut national de santé publique du Québec, Montréal Québec, 2023, ISBN: 9782550959922.
Potential Factors Influencing Adoption of a Primary Care Pathway to Prevent Functional Decline in Older Adults
Journal ArticleCan Geriatr J, 26 (2), 2023.
The OptimaMed intervention to reduce medication burden in nursing home residents with severe dementia: results from a pragmatic, controlled study
Journal ArticleBMC Geriatr, 23 (1), 2023.
Job Satisfaction for Caregivers and Other Employees in Innovative Long-Term Care Homes for Residents With Cognitive Problems
Journal ArticleJ Gerontol Nurs, 49 (10), 2023.
Perceptions and Preoccupations of Patients and Physicians Regarding Use of Medical Cannabis as an Intervention Against Chronic Musculoskeletal Pain: Results from a Qualitative Study
Journal ArticleJ Pain Res, 16 , 2023.
Using co-creation focus groups to customise a remote multidomain programme designed to increase dementia literacy
Journal ArticleBMJ Open, 13 (9), 2023.
Experience and Appreciation of Health Care Teams Regarding a New Model of Pharmaceutical Care in Long-Term Care Settings
Journal ArticleCan J Aging, 41 (3), 2022.
A nursing mentoring programme on non-pharmacological interventions against BPSD: Effectiveness and use of antipsychotics-A retrospective, before-after study
Journal ArticleNurs Open, 9 (1), 2022.
Reorganizing Pharmaceutical Care in Family Medicine Groups for Older Adults With or at Risk of Major Neurocognitive Disorders: Protocol for a Mixed Methods Study
Journal ArticleJMIR Res Protoc, 11 (11), 2022.
Active projects
- Projet GPS: Évaluation de l'impact de la réorganisation du travail en Groupe de médecine de famille (GMF) sur la Pharmacothérapie et le Soutien à l'autonomie des personnes âgées ayant un trouble neuro-cognitif majeur, from 2019-04-01 to 2025-03-31
- Quels facteurs influencent la réadmission à 30 jours chez les patients âgés et très âgés, hospitalisés pour Insuffisance cardiaque ? Étude utilisant des méthodes mixtes dans l'hôpital St-Sacrement du CHU de Qc., from 2024-02-20 to 2025-03-31
- Traduction et adaptation culturelle pour le Québec d’un questionnaire mesurant l’usage médical du cannabis, from 2022-04-01 to 2024-10-30
Recently finished projects
- La collaboration entre les pharmaciens GMF et communautaires, les médecins de famille et infirmières des GMF pour soutenir l’autonomie des aînés ayant des troubles cognitifs, from 2023-05-01 to 2024-04-30
- La part du traitement de la douleur chronique non ancéreuse d’origine musculosquelettique parmi les indications cliniques de nouvelles ordonnances d’opioïdes au Québec , from 2021-04-01 to 2024-03-31
- La qualité des soins gériatriques à la Clinique de gériatrie de Québec et leurs partenaires de la Société Alzheimer de Québec – Début d’un laboratoire vivant en marge de la COVID, from 2023-04-01 to 2024-03-31
- Phase Two of the Canadian Consortium on Neurodegeneration in Aging, from 2019-04-01 to 2024-03-31
- Projet de recherche sur les modèles novateurs de milieu de vie des aînés atteints de problèmes cognitifs : similitudes, différences, forces et défis, from 2019-04-01 to 2023-03-31
- Validation du questionnaire d’Auto-repérage pour Vieillir En Santé (AVES) pour permettre aux personnes aînées d’évaluer elles-mêmes leurs risques de perte d'autonomie, from 2021-03-01 to 2023-03-31